FEATURED CONTRIBUTED CONTENT

NORD 2017 Rare Impact Awards


NORD 2017 Rare Impact Awards

NORD’s signature fundraising event – the Rare Impact Awards continue NORD’s 32-year tradition of celebrating progress made in rare diseases and honoring the extraordinary work of the community. This event renews our collective commitment, energy, and focus on providing critical advancements and services to help the 30 million Americans with rare diseases. NORD is requesting […]

April 17, 2017 More Clinical »
Leveraging FDA’s Expedited Programs: Now and in the Future


Leveraging FDA’s Expedited Programs: Now and in the Future

FDA is committed to advancing the development of therapies that treat serious conditions and rare diseases. As part of this commitment, FDA offers expedited programs for biopharmaceutical companies to reduce development and review timelines for new drugs and biologics that address unmet medical needs. In this webinar, Cardinal Health regulatory experts will examine FDA’s four […]

April 12, 2017 More Clinical »
Speak Out


Speak Out

Calling out Clinical Technology Think about your phone – maybe you are even reading this on it – and you’ll probably have an emotional reaction of some kind. It may or may not be a strong reaction, but odds are there is a certain and specific feeling your phone emotes in you. For something that […]

March 1, 2017 More Clinical »
Fresh Insights on FDA Data Standards


Fresh Insights on FDA Data Standards

Chiltern has recently worked with PharmaVOICE to publish a white paper and a related podcast about the FDA’s latest guidances on data standards for clinical research. I highly encourage you to check out these informative pieces if you are interested in this topic. White Paper: The Case for Embracing the FDA’s Endorsed Data Standards Download Podcast: Navigating […]

March 13, 2017 More Clinical »
Increasing Enrollment While Reducing Sites


Increasing Enrollment While Reducing Sites

After decades of delayed trial timelines, slow site setup and poor patient enrollment remain the top barriers to completing clinical studies on time and on budget. However, a new trial model has surfaced that flattens these obstacles and provides sponsors with the enrollment and budget certainty they need to more effectively plan for study launch […]

April 11, 2017 More Clinical »
Six Ways to Improve Your Clinical Trial Budget


Six Ways to Improve Your Clinical Trial Budget

Smaller companies have unique needs in regards to clinical trials. Historically, vendors have approached the clinical trials industry with a “one size fits all” technology approach that is too big, expensive and cumbersome to maintain, or provides little actual value for what the company actually wants to solve. This white paper introduces a solution ideally suited for the […]

March 24, 2017 More Clinical »
Mobile Apps: a 360° Guide For Clinical Trials


Mobile Apps: a 360° Guide For Clinical Trials

Mobile apps are an important link between researchers and patients, but using them in clinical development requires rigorous preparation. Download this white paper to learn more about data strategies for mobile apps throughout the trial life cycle, the current and future regulatory environment, and how to provide deeper patient engagement.

March 31, 2017 More Clinical »
Expediting Drug Approval


Expediting Drug Approval

For patients with serious and rare diseases, time is of the essence, and the traditional drug development process may take far too long. To speed innovative new drugs to market, the FDA has established four expedited programs that allow the development process to be compressed and evidence of the drug’s effectiveness gathered as efficiently as […]

April 3, 2017 More Clinical »
Mental Health: An Insurance Industry Perspective


Mental Health: An Insurance Industry Perspective

No group of stakeholders wields greater influence over patient access to medicines than payers making reimbursement and formulary decisions. Even in a time of policy upheaval in Washington, health plans must make sure members get the medicines they need. Insurers say they’re committed to this role when it comes to mental health conditions, which affect one in five American […]

April 6, 2017 More Clinical »
Digitizing the Global Life Sciences Supply Chain: The Critical Role of Digital Transaction Management


Digitizing the Global Life Sciences Supply Chain: The Critical Role of Digital Transaction Management

Life science companies are experiencing a significant transformation in how they bring new products to market. Organizations must adapt to changes in the marketplace, such as global product commercialization, specialized medicine, new regulations, new payment models, and new technology that are driving more product variety, smaller drug volumes, and shorter product life cycles. To meet […]

April 3, 2017 More Clinical »
FEEDBACK